The role of Ile3434Thr XRCC7 gene polymorphism in differentiated thyroid cancer risk in an Iranian population

Iranian Biomedical Journal

Volumn 16, Issue 4, 2012, Pages 218-222

  Rahimi, Maryam ^a   Fayaz, Shima ^b   Fard Esfahani, Armaghan ^c   Modarressi, Mohammad Hossein ^d   Akrami, Seyed Mohammad ^d   Fard Esfahani, Pezhman ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DNA repair enzymes; Genetic polymorphism; Thyroid neoplasms

Indexed keywords

DNA; ISOLEUCINE; THREONINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DNA SEQUENCE; FEMALE; GENE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; XRCC7 GENE;

ADULT; AGED; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA-ACTIVATED PROTEIN KINASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; THYROID NEOPLASMS;

EID: 84871829068     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: 10.6091/ibj.1078.2012     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90.
2. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009 Aug;115(16):3801-7.
3. Tronko MD, Howe GR, Bogdanova TI, Bouville AC, Epstein OV, Brill AB et al. A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. J Natl Cancer Inst. 2006 Jul;98(13):897-903.
4. Rivkees SA, Mazzaferri EL, Verburg FA, Reiners C, Luster M, Breuer CK etal. The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. Endocr Rev. 2011 Dec;32(6):798-826.
5. Adjadj E, Schlumberger M, de Vathaire F. Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer. Lancet Oncol. 2009 Feb;10(2):181-90.
6. West SC. Molecular views of recombination proteins and their control. Nat Rev Mol Cell Biol. 2003 Jun;4(6): 435-45.
7. Meek K, Gupta S, Ramsden DA, Lees-Miller SP. The DNA-dependent protein kinase: the director at the end. Immunol Rev. 2004 Aug;200:132-41.
8. Lees-Miller SP, Meek K. Repair of DNA double strand breaks by non-homologous end joining. Biochimie. 2003 Nov;85(11):1161-73.
9. Pawelczak KS, Turchi JJ. A mechanism for DNA-PK activation requiring unique contributions from each strand of a DNA terminus and implications for microhomology-mediated nonhomologous DNA end joining. Nucleic Acids Res. 2008 Jul;36(12):4022-31.
10. Long XD, Yao JG, Huang YZ, Huang XY, Ban FZ, Yao LM et al. DNA repair gene XRCC7 polymorphisms (rs#7003908 and rs#10109984) and hepatocellular carcinoma related to AFB1 exposure among Guangxi population, China. Hepatol Res. 2011 Nov;41(11):1085-93.
11. Mandal RK, Kapoor R, Mittal RD. Polymorphic variants of DNA repair gene XRCC3 and XRCC7 and risk of prostate cancer: a study from North Indian population. DNA Cell Biol. 2010 Nov;29(11):669-74.
12. Wang SY, Peng L, Li CP, Li AP, Zhou JW, Zhang ZD et al. Genetic variants of the XRCC7 gene involved in DNA repair and risk of human bladder cancer. Int J Urol. 2008 Jun;15(6):534-9.
13. Sturgis EM, Zhao C, Zheng R, Wei Q. Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis. Laryngoscope. 2005 Jun;115(6):938-45.
14. Available from: http://www.ncbi.nlm.nih.gov/projects /SNP/snp_ref.cgi?geneId=5591.
15. Kasiulevičius V, Šapoka V, Filipavičiūtė R. Sample size calculation in epidemiological studies. Gerantologija. 2006;7(4):225-31.
16. Siraj AK, Al-Rasheed M, Ibrahim M, Siddiqui K, Al-Dayel F, Al-Sanea O et al. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. J Endocrinol Invest. 2008 Oct;31(10):893-9.
17. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes, 2005. Mutat Res. 2005 Sep;577(1-2):275-83.
18. Chen BP, Chan DW, Kobayashi J, Burma S, Asaithamby A, Morotomi-Yano K et al. Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. J Biol Chem. 2005 Apr;280(15):14709-15.
19. Olsen BB, Fischer U, Rasmussen TL, Montenarh M, Meese E, Fritz G et al. Lack of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is accompanied by increased CK2alpha' levels. Mol Cell Biochem. 2011 Oct;356(1-2):139-47.
20. Convery E, Shin EK, Ding Q, Wang W, Douglas P, Davis LS et al. Inhibition of homologous recombination by variants of the catalytic subunit of the DNAdependent protein kinase (DNA-PKcs). Proc Natl Acad Sci USA. 2005 Feb;102(5):1345-50.
21. Gangwar R, Ahirwar D, Mandhani A, Mittal RD. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population? Mutat Res. 2009 Nov-Dec;680(1-2):56-63.
22. Liu Y, Zhang H, Zhou K, Chen L, Xu Z, Zhong Y et al. Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis. 2007 Sep;28 (9):1906-1.